Cell, Gene, Tissue Standards

Cell, gene, and tissue therapies are revolutionizing modern healthcare, holding the promise to treat and even cure a spectrum of previously intractable conditions. USP is leading the charge to establish cutting edge standards in the cell and gene therapy arena, ensuring these novel therapies meet the highest quality, safety, and efficacy benchmarks. Working with industry frontrunners, medical experts, and regulators, USP is streamlining the transition of cell and gene therapies from ground-breaking research to mainstream clinical practice, making advanced treatments both effective and widely available. As the realm of cell and gene therapies expands, USP continues to lay the groundwork necessary for their quality product development, validation, and integration into global healthcare systems.

Explore AVV Interactive toll for choosing AVV gene therapy quality and safety resources.

NEW! Gene Therapy Analytical Guide

Explore the new Gene Therapy Analytical Guide, an online interactive tool that places quality control solutions at your fingertips.

Access Now!

Cell, Gene, Tissue Families

Please click on the Adeno-associated viral vector (AAV), Cell and Tissue, or Lentiviral vector (LV) family button to learn more.

AAV

USP Monographs

USP-NF Chapters

USP Monographs

USP-NF Chapters

LVV

USP Monographs

USP-NF Chapters

What's New

Spotlight

Cell & Gene Therapy Insights

stakeholder forum

USP hosts Stakeholder Forum on Innovative Analytical Approaches to Cell & Gene Therapy

webinar

USP and ATCC deliver Webinar on Residual DNA Testing Solutions

 

sign up for updates
sign up for updates

Sign up for updates